A Sensitive and Robust HPLC Assay with Fluorescence Detection for the Quantification of Pomalidomide in Human Plasma for Pharmacokinetic Analyses

Pomalidomide is a second generation IMiD (immunomodulatory agent) that has recently been granted approval by the Food and Drug Administration for treatment of relapsed multiple myeloma after prior treatment with two antimyeloma agents, including lenalidomide and bortezomib. A simple and robust HPLC...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Shahbazi, Shandiz, Peer, Cody J., Polizzotto, Mark N., Uldrick, Thomas S., Roth, Jeffrey, Wyvill, Kathleen M., Aleman, Karen, Zeldis, Jerome B., Yarchoan, Robert, Figg, William D.
Format: Artigo
Idioma:Inglês
Publicat: 2014
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3943695/
https://ncbi.nlm.nih.gov/pubmed/24486861
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jpba.2014.01.001
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars